Skip to main content
. Author manuscript; available in PMC: 2009 Jan 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2007 Mar 29;61(1):133–144. doi: 10.1007/s00280-007-0458-z

Fig. 3.

Fig. 3

Rapamycin concentration–time profile in plasma after IV administration of control rapamycin (filled square), rapamycin in PEG-b-PCL (open square), and rapamycin in PEG-b-PCL + α-tocopherol formulation (open circle) (10 mg/kg) to rats (mean ± SEM, n = 4 per group)